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Abstract
IRF8 (Interferon Regulatory Factor 8) plays an important role in defenses against intracellular pathogens, including several
aspects of myeloid cells function. It is required for ontogeny and maturation of macrophages and dendritic cells, for
activation of anti-microbial defenses, and for production of the Th1-polarizing cytokine interleukin-12 (IL-12) in response to
interferon gamma (IFNc) and protection against infection with Mycobacterium tuberculosis. The transcriptional programs
and cellular pathways that are regulated by IRF8 in response to IFNc and that are important for defenses against M.
tuberculosis are poorly understood. These were investigated by transcript profiling and chromatin immunoprecipitation on
microarrays (ChIP-chip). Studies in primary macrophages identified 368 genes that are regulated by IRF8 in response to
IFNc/CpG and that behave as stably segregating expression signatures (eQTLs) in F2 mice fixed for a wild-type or mutant
allele at IRF8. A total of 319 IRF8 binding sites were identified on promoters genome-wide (ChIP-chip) in macrophages
treated with IFNc/CpG, defining a functional G/AGAAnTGAAA motif. An analysis of the genes bearing a functional IRF8
binding site, and showing regulation by IFNc/CpG in macrophages and/or in M. tuberculosis-infected lungs, revealed a
striking enrichment for the pathways of antigen processing and presentation, including multiple structural and enzymatic
components of the Class I and Class II MHC (major histocompatibility complex) antigen presentation machinery. Also
significantly enriched as IRF8 targets are the group of endomembrane- and phagosome-associated small GTPases of the IRG
(immunity-related GTPases) and GBP (guanylate binding proteins) families. These results identify IRF8 as a key regulator of
early response pathways in myeloid cells, including phagosome maturation, antigen processing, and antigen presentation
by myeloid cells.
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Introduction
The defense mechanisms of mononuclear phagocytes that are
circumvented by successful intracellular pathogens are poorly
understood [1]. Genes and proteins in these pathways may represent
valuable targets for therapeutic interventions in the corresponding
diseases. Such host defense mechanisms can manifest themselves as
genetic determinants of innate resistanceor susceptibility to infections
in human populations [2,3], and in corresponding animal models of
experimental infections [4,5]. Forward genetic studies of naturally
occurring or experimentally induced mutations in mice may identify
such genes and proteins [5,6], which relevance to the corresponding
human infection can be established in parallel studies of human
populations from areas of endemic disease [2,5,6].
In inbred mouse strains, susceptibility to infection with several
intracellular pathogens including Mycobacterium, Salmonella and
Leishmania, is determined in part by the natural resistance-
associated macrophage protein 1 (Nramp1) gene (Slc11a1). In
resistant mice, Slc11a1 functions as an efflux pump for Fe
2+ and
Mn
2+ ions at the membrane of microbe-containing phagosomes
formed in macrophages, thereby restricting microbial access to
these essential nutrients [7]. In humans, polymorphic variants at
or near SLC11A1 have been associated with differential suscepti-
bility to mycobacterial infections including tuberculosis, leprosy,
and Buruli ulcer [6]. In addition, monocytes derived from
individuals bearing SLC11A1 alleles associated with tuberculosis
susceptibility in field studies, display reduced functional activity of
the SLC11A1 protein [8]. A search for genetic modifiers of the
protective effect of Slc11a1 identified the BXH2 mouse strain as
highly susceptible to Mycobacterium bovis (BCG; bacillus Calmette-
Gue ´rin) infection despite presence of resistance-associated Slc11a1
alleles (Slc11a1
Gly169) [9]. By positional cloning, we determined that
PLoS Genetics | www.plosgenetics.org 1 June 2011 | Volume 7 | Issue 6 | e1002097susceptibility to infection in BXH2 is caused by a mutation
(R294C) in the interferon regulatory factor 8 (IRF8) (Ensembl:EN-
SMUSG00000041515) [9].
IRF8 is one of 9 members of the Interferon Regulatory Factor
(IRF) family. IRF8 has a DNA binding domain (DBD; 120 a.a) of
the helix-turn-helix type that binds to ISRE (Interferon Stimulated
Response Elements) sites present in the proximal promoters of
type II IFN-regulated genes. IRF8 also has an IRF association
domain (IAD) that serves as a recruitment module for other
transcription factors. IRF8 is expressed primarily in macrophages
and dendritic cells, but is also detected in T and B lymphocytes
[10]; and upon stimulation with interferon gamma (IFNc),
lipopolysaccharide (LPS), pathogen-associated molecular patterns
(PAMPs) and other microbial stimuli, IRF8 binds to ISREs in
association with other members of the IRF (e.g. IRF1), or ETS
(e.g. PU.1, TEL) families, or other hetero-dimerization partners, to
activate or repress gene expression in these cells [11]. The IRF8-
PU.1 heterodimer leads to the activation of genes containing ETS-
IRF composite element (EICE, GGAAnnGAAA), the ETS-IRF
response element (EIRE, GGAAAnnGAAA) or to the IRF-ETS
composite sequence (IECS, GAAAnn(n)GGAA) [12]. IRF8 plays
an important role in several physiological aspects of myeloid cells
development and function. IRF8 drives differentiation of myeloid
progenitors towards mononuclear phagocytes, while positively
regulating apoptosis of the granulocytic lineage [11,13]. Macro-
phages from IRF8-deficient mice remain immature, including
altered expression of intrinsic macrophage anti-microbial defenses
[11], and are susceptible to ex vivo infection with M. bovis [14],
Salmonella typhimurium [14], and Legionella pneumophila [15]. IRF8-
deficient mice also show a profound defect in dendritic cells (DCs),
as they lack both CD11c
+CD8a
+ DCs and pDCs [16]. In addition,
the small number of CD11c
+CD8a
+ and CD8a
2 DCs present in
these mice remain immature and fail to up-regulate co-stimulatory
molecules and to produce key cytokines in response to microbial
products [16–18]. In addition, IRF8 is required for Th1
polarization of early immune response [11]. This cooperation
between antigen presenting cells (APCs) and T/NK cells, involves
IFNc binding to its receptor (IFNcR) which causes STAT1 (signal
transducers and activators of transcription) activation. STAT1
trans-activates IRF8 expression leading to IL-12p40 production by
dendritic cells, and engagement of the interleukin 12 receptor
(IL12R) on Th1 cells further amplifies IFNc production [11].
IRF8 binds to the promoter regions, and is required for activation
of IL-12p40 [19,20], IL-12p35 and IL-18 genes in DCs in
response to IFNc [11,19,20]. IRF8
2/2 mice do not produce IL-
12p40, lack Th1 polarization (absence of antigen specific CD4
+,
IFNc producing T cells), and are susceptible to in vivo infection
with intracellular pathogens [19,21–24].
We have shown that the IRF8
R294C isoform of BXH2 behaves as
a partial loss-of-function which is associated with impaired IL-
12p40 production by BXH2 splenocytes, and loss of trans-
activation of a IL-12p40 reporter construct in vitro. The IRF8
R294C
mutation results in increased M. bovis (BCG) multiplication both
early and late during infection, with uncontrolled replication
linked to inability to form granulomas in infected liver and spleen.
The IRF8
R294C mutation also causes susceptibility to S. typhimurium
to a level comparable to that seen for mice lacking functional
Nramp1 or Tlr4 (Toll-like receptor 4), and impairs innate and
adaptive immune defenses against the blood-stage malarial
parasite Plasmodium chabaudi AS [25]. BXH2 mice are also
extremely susceptible to aerosol infection with Mycobacterium
tuberculosis, showing uncontrolled intracellular pathogen replication
in lung macrophages, impaired granuloma formation, rapid
dissemination of the infection to distant sites, and rapid necrosis
of infected tissues, and early death. There was complete absence of
IL-12p40 induction, severely reduced IFNc production, and
impaired T cell priming in the lungs of infected BXH2,
highlighting the critical role of IRF8 in this response [26]. These
studies have identified IRF8 as a key regulator of host defenses
against Mycobacteria.
In this study, we have used transcript profiling with microarrays
and chromatin immunoprecipitation (ChIP) hybridization on
genomic DNA arrays (ChIP-chip) in macrophages from normal
and IRF8-deficient mice, to systematically identify genes tran-
scriptionally regulated by IRF8 a) during ontogeny and matura-
tion of macrophages, and b) in response of these cells to combined
exposure to IFNc and Tlr9 (Toll-like receptor 9) ligand (CpG), and
c) during pulmonary tuberculosis in vivo. In these studies, we
incorporated an experimental strategy based on the co-segregation
of IRF8-dependent differential gene expression in macrophages
from [BALB/c6BXH2] F2 animals selected for homozygosity for
either wild-type (wt; IRF8
R294) or mutant (IRF8
C294) IRF8 alleles.
These studies have identified a critical role for IRF8 in regulating
expression of genes and associated cellular pathways responsible
for early interaction with pathogens, phagosome maturation,
antigen processing and antigen presentation to CD4
+ and CD8
+ T
cells.
Results
Identification of IRF8-Dependent eQTLs Segregating in
F2 Animals
To identify transcriptional targets of IRF8 that play a role in a)
macrophage maturation, and b) in activation in response to IFNc
and microbial products, we used transcript profiling to compare
RNA expression in macrophages bearing either a wild-type (wt) or
a mutant allele at IRF8 (R294C). For this, we used bone marrow-
derived macrophages (BMDMs) from individual [BALB/
c6BXH2] F2 mice of mixed genetic background but that were
identified as homozygote for either wt (IRF8
R294) or mutant
(IRF8
C294) IRF8 alleles. This strategy [27] is based on the
observation that complex gene expression profiles (eQTLs) caused
by a null mutation at a specific gene show extremely robust
Author Summary
IRF8 is a member of the Interferon Regulatory Factor family
that is expressed in myeloid cells such as macrophages
and dendritic cells and that activates or represses gene
transcription upon stimulation with interferon gamma
(IFNc), lipopolysaccharide (LPS), and other microbial
stimuli. IRF8 plays an important role in several aspects of
myeloid cells, including differentiation and maturation of
early progenitor cells, expression of intrinsic anti-microbial
defenses, and production of the interleukin-12 (IL12)
cytokine, which is essential for priming of early T cell–
mediated immune response. IRF8 mutant mice are
susceptible to a number of intracellular infections includ-
ing pulmonary tuberculosis. The transcriptional and
cellular pathways regulated by IRF8 and essential for
resistance to infections were studied by a combination of
genome-wide methods, including transcriptional profiling
and chromatin immunoprecipitation (ChIP-chip). These
studies identified phagosome maturation, antigen pro-
cessing, and antigen presentation as critical pathways in
early host–pathogen interactions regulated by IRF8 in
macrophages exposed to IFNc/CpG and in lung tissues
infected with Mycobacterium tuberculosis.
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recombinant congenic lines [30] derived from parental strains
bearing wt and mutant alleles at the gene of interest. Gene
expression profiles detected in common in macrophages from F2
animals of either wt or mutant IRF8 genotypes but that show
mixed genetic background (C57BL/6J, C3H/HeJ, BALB/cJ), can
distinguish true IRF8-dependent effects from irrelevant ones
caused by differences in genetic background of the two parental
mouse strains. This strategy is well suited to study eQTLs caused
by absence versus presence of a transcription factor such as IRF8.
In this approach, individual F2 mice (6 samples per experimental
group) are used both as biological and technical replicates, to
increase the stringency of the analysis. BMDMs from wt and
IRF8
C294 F2 mice were stimulated or not with IFNc/CpG, and
RNA was isolated and used for transcript profiling.
IRF8-Dependent Transcript Profiles Associated with
Macrophage Maturation
IRF8 plays a critical role in maturation of monocytes,
macrophages and dendritic cells, and mice bearing mutations at
IRF8 have defects in these cell types [11]. To identify IRF8
transcriptional targets that may play a role in maturation of the
myeloid lineage, we compared transcript profiles in resting
BMDMs from wt and IRF8 mutant F2 mice (Figure 1A). A
pairwise analysis (t test p value,0.05; fold change $1.5X)
identified a total of 454 genes differentially expressed in an
IRF8-dependent fashion in these cells at basal level (Table S1). Of
these 454 genes, 219 were more highly expressed in wt cells, while
235 were more highly expressed in mutant BMDMs (Table S1).
Hierarchical clustering of the 454 genes according to expression
pattern similarities in the 12 independent microarrays readily
separated the 6 individual wt mice from the 6 individual mutant
mice (data not shown), illustrating the robustness of the approach.
A gene ontology (GO) report on these 219 and 235 genes
separately, revealed that 39 (17.8%) and 45 (19.1%) of them were
associated with ‘response to stimulus’, representing the most
abundant group (data not shown). Additional enriched gene
clusters included GO-terms such as immune system development,
immune system process, response to stress, intracellular signaling
cascade, immune response, defense response, transcription, and
others. Genes most positively regulated by IRF8 in resting cells
included genes involved in a) antigen processing and presentation
(CD74, H2-AbI, H2-Eb1, H2-Ea), b) cytokines and chemokines
production and signaling (Cxcl14, Cxcl16, Socs2, Ciapin1, the C1q
complex, Il17ra), c) growth regulation (Csf3r), d) tissue remodeling
(Timp1, Vcam1), and e) rapid response to microbial insults (Mx1,
Ifitm1, Tnfaip3, Ly86) [see Table S1 for annotation]. Together
these genes may correspond to direct IRF8 targets or may
represent markers of maturation differentially expressed in
response to the block caused by loss of IRF8 function in BMDMs.
IRF8-Dependent Transcript Profiles Associated with
Macrophage Activation by IFNc/CpG
To systematically identify IRF8 targets that are important for
IFNc-induced macrophage activation, we compared gene expres-
sion profiles obtained in BMDMs from wt and IRF8 mutant F2
mice following exposure to IFNc/CpG (stimulated versus control).
A first pairwise analysis (t test p value,0.05; fold change $1.5X)
identified a total of 2501 (1247 induced; 1254 repressed) and 1904
(828 induced; 1076 repressed) genes significantly regulated by
IFNc/CpG in wt and IRF8 mutant mice, respectively (Figure 1A).
A subset of these genes (76 genes in wt only, 40 genes in IRF8
mutant only, and 138 genes in both groups) were also regulated by
IRF8 at the basal level, in the absence of IFNc/CpG stimulation
(Figure 1B and Table S2).
Secondly, and to take into account possible IRF8-dependent
expression differences at basal level, we carried out a two-way
(262 interaction) Anova analysis [29]. In this analysis, expression
levels before and after IFNc/CpG treatment are calculated and
expressed as ratios, and a statistical analysis is conducted to
identify genes which ratio of expression are affected by IRF8 [wt,
Figure 1. Pairwise analysis of transcriptional responses of wt
and IRF8 mutant BMDMs at basal level and following exposure
to IFNc/CpG. BMDMs RNA was obtained from individual wt and IRF8
mutant F2 mice either prior to (unstimulated control) or 3 hrs following
stimulation with IFNc/CpG (6 samples per experimental group; 24
samples in total), and hybridized to microarrays. The 3 hrs IFNc/CpG-
stimulated macrophage cultures were initially primed with IFNc (50 U/
ml) for 18 hrs. (A) A closed-loop strategy was applied to monitor
differences in transcript abundance between the four experimental
groups; (comparison a) mutant control versus wt control; (comparison
b) wt stimulated versus wt control; (comparison c) mutant stimulated
versus mutant control; (comparison d) mutant stimulated versus wt
stimulated. The numbers of significantly modulated transcripts
identified for each single pairwise comparison are indicated within
the gray arrows. (B) A Venn diagram analysis of the pairwise
comparisons a, b, and c revealed considerable overlaps in the lists of
transcripts which level of expression is affected by the IRF8 alleles and
the IFNc/CpG stimulation.
doi:10.1371/journal.pgen.1002097.g001
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stimulated versus unstimulated] with a t-test p value,0.05 and a
fold change $1.5X. This comparison identified 368 genes that
were significantly regulated by IRF8 in response to IFNc/CpG
(Figure 2A and Table S3). Hierarchical clustering according to
expression pattern similarities not only distinguished the control
from treated groups (IFNc/CpG), but also separated wt from IRF8
mutant BMDMs and this for both conditions (dendrogram in
Figure 2A). A subset of 80 genes showed particularly robust IRF8
dependence in expression in response to IFNc/CpG, while
showing no significant IRF8-dependent effects at basal levels
(indicated in bold in Table S3). This list contained many genes
known to play a key role in several aspects of macrophage
function, including a) cytokine-cytokine receptor interaction (Ccl8,
Ccr3, Il13ra1), b) antigen presentation (H2-DMb2, Ciita), c) tissue
remodeling (Angptl4, Col18a1, Mmp13), d) detoxification (Cyp27a1,
Cyp4f18, Cyp51, Por, Ephx1), e) cell surface receptors (Igh-6, Tfrc)
and adhesion molecules (Siglec1), and Irf4, a member of the IRF
family know to functionally interact with IRF8 to regulate gene
expression [11]. A subset of 8 transcripts (Ephx1, Cyp27a1, Ciita,
Il10ra, Ms4a7, C1qb, Angptl4, and Slc40a1) strongly induced by
IFNc/CpG in an IRF8-dependent manner, were selected for
further validation by quantitative PCR (qPCR). For all the genes
tested, we observed an excellent correlation between the level and
degree of differential expression initially detected by transcript
profiling and results from qPCR analysis (Figure 2B and 2C).
Identification and Characterization of IRF8 Binding Sites
in Activated Macrophages by Chromatin
Immunoprecipitation (ChIP-Chip)
Transcript profiling analyses revealed that IRF8 intervenes in a
complex transcriptional network. To identify which genes in this
network are direct IRF8 transcriptional targets of (as opposed to
secondary targets), we hybridized IRF8-bound chromatin ob-
tained by immunoprecipitation (ChIP) from cultured macrophages
treated with IFNc/CpG to Agilent promoter tiling arrays (ChIP-
chip). Following normalization and statistical analysis, we
identified 319 IRF8 binding events corresponding to 333 different
genes (Table S4). These binding sites were selected for a) a
minimum of 2-fold enrichment over control ChIP carried out
using non-immune serum, and b) a p value#0.001. In this list, we
validated IRF8 recruitment to Ifnb promoter by ChIP-qPCR (data
not shown). Moreover, this list contains several published IRF8
binding sites (Tlr4, Oas2, Cybb, Ifitm3, Etv3, Lyz and Tlr9) and
shows a significant 43% overlap with the recently published IRF8
ChIP-chip study performed on chromatin from human monocytes
[31]. To analyse closely the IRF8 binding sequence, we
determined the chromosomal position for the center of each
binding peak, and extracted 500 bp of peak flanking sequence
using the mouse mm8 genome assembly. These sequences were
queried for de novo motif discovery with different algorithms
(MEME, MDscan and AlignAce), and all produced the same IRF8
DNA binding motif (G/AGAAnTGAAA) as the top matrix
(Figure 3A and Figure S1A) [32–34]. This highly significant motif
(MEME E-value=8.3
2385) is in agreement with the known
Transfac database IRF8 binding motif (ICSBP_M00699; Figure
S1B), although there is no requirement for the 39 CTG bases that
are more characteristic of the ISGF3 (Stat1/Stat2/IRF9) ISRE
binding site (Figure 3A). This de novo binding site is closer to a
standard IRF site which is characterized by a 2 nucleotide spaced
tandem repeat of GAAA, with an important difference, the first
base is mostly occupied by a guanine. A comparable GGAAnn-
GAAA motif was previously described as ETS-IRF composite
element (EICE) [12]. However, the motif identified in the present
study gives importance to a T placed in the sixth position. This de
novo derived motif was found at least once within a 1000 bp
segment of 87% (277 out of 319) of the IRF8 binding sites
identified by ChIP-chip. A comparison of the de novo defined IRF8
site with known ISRE and IRF1 binding motif show they all
cluster at the peak of enrichment, with the highest number for the
de novo IRF8 site (Figure 3B).
Other predominant motifs were identified in our dataset by de
novo analysis. Their similarity to known Transfac v11.3 database
was assessed using the STAMP web-tool [35]. With the
MatInspector motif search tool, we measured the fold enrichment
of each de novo and known motifs occurrence in our dataset
compared to similar sets of random sequences (Table S5). As
expected, all the matrices from IRF family were enriched; ETS
family motifs were also enriched because the GGAA sequence
which forms part of their binding site (GAGGAA) is imbedded
within the IRF8 binding site. We detected a strong association
(,50% of sites) between the de novo generated IRF8 motif and
binding sites for PU.1, the major ETS factor in macrophages, with
co-localization of the two sites at the binding peak (Figure 3C). In
addition, we noted an enrichment of AP-1 sites: of the 277 IRF8
motif containing peaks, 73 (26%) also contain an AP-1 predicted
site with a tendency of these sites to be centered at the peak of
enrichment, although not as clearly as for PU.1 (Figure 3D).
A Gene Ontology (GO) analysis with the DAVID (database for
annotation, visualization and integrated discovery) web-tool for
genes exhibiting an IRF8 binding peak detected by ChIP-chip
revealed a strong enrichment for the ‘‘immune response’’ category
(29 genes, p value=5.3e10
29) (Table S6) [36,37]. This list includes
several genes encoding proteins involved in recognition, processing
and presentation of antigens by antigen-presenting cells (APCs).
Indeed, it includes members of the Toll-like receptors (TLR)
family that play a crucial role in recognition of pathogen-
associated molecular signatures, including Tlr4 (interaction with
LPS from Gram-negative bacteria), Tlr9 (unmethylated CpG
containing DNA) and Tlr13 (vesicular stomatitis virus) (Figure 4A)
[38]. KEGG (Kyoto encyclopedia of genes and genomes) pathway
enrichment analysis identifies several genes that play a key role in
antigen processing and presentation in dendritic cells and
macrophages, including Class I and Class II MHC (major
histocompatibility complex) molecules, as well as proteases,
membrane transporters and structural proteins involved in
generation, transport and loading of antigenic peptides onto Class
I or Class II molecules (Figure 4B and Table S6). Finally, we also
note an enrichment of IRF8 binding peaks in the GO term
nucleotide binding. Strikingly, many of the genes contained in that
list include members of the IFN-inducible GTPase superfamily,
including the Gbp (guanylate binding proteins), Mx, and p47 (Irg;
immunity-related GTPases) families which are involved in early
innate immune response to intracellular infection in many cell
types (Figure 4B, 4C and Table S6) [39–41].
Identification of Direct IRF8 Targets That Are Regulated
by IFNc in Macrophages In Vitro and in the Lung during
Pulmonary Tuberculosis
To identify direct functional targets of IRF8 in macrophages, we
overlapped the list of IRF8 binding peaks (ChIP-chip) with the list
of genes differentially regulated by exposure to IFNc/CpG in
macrophages from F2 mice bearing wt alleles at IRF8. This
intersection included 145 direct IRF8 targets controlled by 111
IRF8 binding sites (Table S7). We also examined the overlap
between IRF8 binding sites detected by ChIP-chip and the genes
which expression in macrophages in regulated by IRF8 in
response to IFNc/CpG (from 262 Anova analysis, Figure 2A
IRF8-Dependent Gene Expression
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fashion and that harbour an IRF8 binding site in their vicinity.
These genes represent transcriptional targets of IRF8 which
expression is regulated by IFNc/CpG in macrophages in an IRF8-
dependent fashion. The vast majority of these 21 genes were
included in the intersection detected between IRF8 binding sites
and genes regulated by IFNc/CpG in wt F2 macrophages (Table
S7).
We also investigated the relevance of IRF8 targets discovered by
ChIP-chip, to host defenses against infections in vivo. IRF8 and
IFNc are required for protection against pulmonary infection with
M. tuberculosis [26], and mice bearing mutations in either gene are
Figure 2. Transcriptional programs elicited by IFNc/CpG exposure in wt and IRF8 mutant F2 mice. BMDMs RNA was obtained from
individual wt and IRF8 mutant F2 mice either prior to (unstimulated control) or 3 hrs following stimulation with IFNc/CpG (6 samples per
experimental group; 24 samples in total), and hybridized to microarrays. (A) By using a 262 interaction Anova analysis, 368 genes were recognized to
be significantly differentially modulated by IRF8 in response to IFNc/CpG exposure between the wt and IRF8 mutant cells. The expression profiles are
ordered by hierarchical clustering; the genes, illustrated by their specific signal intensities (Log2 scale) are displayed as rows and individual mouse
samples/conditions as columns. Red coloring signifies high level of expression; green coloring denotes low level of expression. The dendrogram
illustrates the clustering of the samples according to expression pattern similarities. RNA samples (6 per experimental group) used for this
transcriptional profiling analysis were pooled and used for qPCR validation. Ephx1, Cyp27a1, Ciita, and Il10ra were selected as genes positively
affected by the presence of functional IRF8 following IFNc/CpG exposure (B), while Ms4a7, C1qb, Angptl4, and Slc40a1 were selected as genes
negatively affected by the presence of a functional IRF8 following IFNc/CpG exposure (C). The ratios of expression (IFNc/CpG-stimulated versus
unstimulated control), represented by fold induction, were calculated for the wt and IRF8 mutant mice separately (white bars), and compared to the
corresponding microarray results (black bars). The black dots indicate the qPCR values obtained for each replicate. The microarray results were
statistically significant according to Anova analysis (t test p value of 0.05 and a fold-change cutoff of 1.5X). Hprt was used to standardize the mRNA
levels of target genes for qPCR.
doi:10.1371/journal.pgen.1002097.g002
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required for development of the dendritic cell lineages, IL-12
production by these cells (Th1 polarization of immune response),
recruitment of T cells to the site of infection, macrophage
activation and containment of infection by activated macrophages
in granulomas [43]. To identify IRF8 targets that may play an
important role in host defenses against pulmonary tuberculosis, we
investigated which of the 319 IRF8 binding sites and associated
genes are significantly regulated in the lungs of C57BL6/J (B6)
mice 30 days following aerosol infection with M. tuberculosis
(pairwise analysis of day 30 versus day 0 transcript profiles) [29].
An intersection of 213 IRF8 binding sites corresponding to 359
associated transcription units was detected in this analysis.
Therefore, ,2/3 of the identified IRF8 targets were found to be
modulated during M. tuberculosis infection in vivo. In addition, there
was considerable overlap between the list of IRF8 targets which
expression was regulated by a) IFNc/CpG stimulation in wt F2
macrophages and b) following M. tuberculosis infection in the lungs
in vivo (Table S7). Gene ontology and KEGG pathway analysis of
these two lists once again identified ‘‘immune response’’ and
‘‘antigen processing and presentation’’ as the key functional
annotation (Table S6). This overlap included a strong focus on
genes playing a role in antigen presentation by Class I and Class II
MHC molecules (CD74, H2-D1, H2-DMa, H2-DMb1/2, H2-Ea,
H2-Eb1, H2-Q8, Ltb, Tapbp1), cytokines, chemokines and their
receptors (Ccl6, Cxcl9, IL6ra, Csfr3, Fcgrt, Tlr9), anti-viral and anti-
bacterial GTPases (Gbp2,3,5,6, Gma1, Rgl2) and other early
response genes (Ifitm1), as well as a numbers of proteolytic
enzymes (erap1, lysosyme, endopeptidase) (Figure 4C, Figure 5,
and Figure 6).
Discussion
In this study, we have used transcript profiling and chromatin
immunoprecipitation on microarrays (ChIP-chip) to investigate
the role of IRF8 in macrophage function, activation by IFNc/
Figure 3. Transcription factor binding motif analyses on IRF8 ChIP-chip binding sites. IRF8 chromatin immunoprecipitated from IFNc
activated macrophages was hybridized to Agilent promoter tiling array (ChIP-chip). After normalization and statistical analysis, we identified 319 IRF8
binding sites with a threshold of 2 fold enrichment and p value#0.001 relative to a non-specific control antibody ChIP. (A) De novo binding motif
analysis was carried out on 500 bp sequence flanking the IRF8 sites. The MEME algorithm returned an IRF-like motif as the top motif with a high
score. The known ISRE and IRF1 motifs are from the Genomatix MatBase database. (B) The 319 IRF8 binding sites were queried for the IRF8 de novo
binding motif and for the ISRE and IRF1 motif shown in A. The position of the in silico found sites was plotted relative to the ChIP-chip IRF8 binding
peak. They all cluster over the peak center, whereas there is no IRF8 motif enrichment in a set of randomly chosen sequences. (C) The PU.1 (ETS family
member) motif shows a clear colocalization with the IRF8 de novo motif, as reported by the in silico analysis. (D) The AP-1 motif is also enriched.
doi:10.1371/journal.pgen.1002097.g003
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PLoS Genetics | www.plosgenetics.org 6 June 2011 | Volume 7 | Issue 6 | e1002097Figure 4. IRF8 regulates important functions of APC cells. (A) IRF8 ChIP-chip binding profiles extracted from the UCSC genome browser for
Toll-like receptors (Tlr4,9,13); Black rectangles represent the significant binding peak and the blue bars correspond to ChIP-chip binding ratios. (B)
Gene ontology (GO) and KEGG pathways analysis of the genes regulated by IFNc-CpG treatment in F2 wt mice and having an IRF8 binding site in
their proximity. The IRF8 targets genes are implicated in immune response, nucleotide binding and antigen processing and presentation. (C) Antiviral
GTPases gene regulation summary. Association of known antiviral GTPases with IRF8 binding sites, IFNc/CpG regulation in wt F2 mice on Illumina
Mouse WG-6 v2.0 Expression BeadChip arrays and regulation after M. tuberculosis infection in B6 mice on Affymetrix oligonucleotides chips (Mouse
Genome 430 2.0 array). N/A indicates that this was not assessed by the microarrays.
doi:10.1371/journal.pgen.1002097.g004
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profiling experiments we compared RNA expression profiles from
BMDMs obtained from mice that bear either a wt (R294) or a
severely hypomorphic IRF8 allele (C294) derived from the mutant
BXH2 mouse strain. In addition, biological and technical RNA
replicates were from independent [BALB/c6BXH2] F2 mice of
mixed genetic background but genotyped for the two IRF8 alleles.
This was done to increase the stringency of the analysis, and to
distinguish true IRF8-dependent effects on gene expression from
irrelevant ones resulting from differences in genetic background of
the wt (C57BL/6J) and mutant animals (BXH2; mixed C57BL/6J,
C3H/HeJ). This approach has been shown to be well suited to
map genome-wide eQTLs that segregate as a result of presence or
absence of a specific transcription factor [27–30]. These
experiments produced several lists of genes which levels of
expression, under different conditions, is influenced by IRF8.
The first list was obtained by comparing BMDMs from wt and
IRF8
C294 mutant mice, and corresponds to genes which basal level
of expression in macrophages is influenced by IRF8 (n=454).
However, because IRF8 plays an important role in maturation of
the myeloid lineage [11,16–18], this list may also include genes not
directly regulated by IRF8, but rather modulated during
macrophages maturation. The second list was obtained by
comparing BMDMs from wt and IRF8
C294 mutant mice treated
with IFNc/CpG (IRF8 genes regulated during macrophage
activation). Two sub-lists were generated, one obtained by
pairwise comparison, and the other generated by a 262
interaction (Anova) analysis which takes into account IRF8-
dependent differences in basal level of expression in absence of
IFNc/CpG stimulation (n=368). Using ChIP-chip experiments
with chromatin prepared from IFNc/CpG activated macrophages
and immunoprecipitated with anti-IRF8 antibodies, we identified
a total of 319 IRF8 binding events (minimum of 2 fold enrichment
over control ChIP and p value#0.001) on a promoter tiling array.
From this information, we further extracted two overlaps and
associated critical gene lists. The first one contains 145 genes and
corresponds to IRF8 targets (bound by IRF8) that are regulated by
exposure to IFNc/CpG in wt F2 macrophages in vitro. The second
one contains 359 genes and corresponds to IRF8 targets (bound by
IRF8) that are regulated during pulmonary infection with M.
tuberculosis in vivo. The above-mentioned lists were generated by
comparing wt cells to those from BXH2 that bear the severely
hypomorphic Irf8
C294 allele; nevertheless, small amounts of
residual activity may remain in Irf8
C294 and gene lists obtained
with this mutant may differ somewhat from those obtained by
comparing wt cell to cells bearing a null Irf8
2/2 allele.
These two gene lists are the most biologically relevant with
respect to the role of IRF8 in macrophage function and defenses
against M. tuberculosis in vivo. A striking feature of these lists is the
preponderance of IRF8 targets associated with antigen recogni-
tion, processing and presentation by antigen presenting cells
(APCs). APCs include dendritic cells, macrophages and B
lymphocytes. These cells capture either soluble or particulate
antigen by scanning different areas of the body including epithelial
surfaces, degrade this antigen and present to T-lymphocytes to
activate immune responses. Although virtually all cells can present
processed peptide antigens to T cells in association with Class I
MHC molecules, so-called ‘‘professional APCs’’ present a wide
range of antigens to T cells in association with Class II MHC
molecules. Many of the genes coding for proteins involved in
antigen recognition, antigen degradation, translocation to a
suitable secretory compartment and Class I and Class II molecules
are encoded by genes within the major histocompatibility locus
(MHC) on mouse Chr. 17 and human Chr. 6.
Presentation of cytosolic peptides via association with Class I
MHC molecules occurs in all cells, and is critical for protection
Figure 5. Enrichment of IRF8 targets within the boundaries of the MHC locus. IRF8 ChIP-chip binding profiles extracted from the UCSC
genome browser for the MHC locus. The black rectangles represent the significant binding peak and the blue bars correspond to ChIP-chip binding
ratios. Genes regulated by IFNc/CpG and/or M. tuberculosis infection are represented by red (activation) and green (repression) boxes.
doi:10.1371/journal.pgen.1002097.g005
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tion of viral or other proteins into short peptides, which are then
translocated into the endoplasmic reticulum (ER) via the tapasin-
associated (Tapap in the ER lumen) ABC transporter heterodimer
TAP1/TAP2. Such peptides entering the ER are further trimmed
by ER-specific aminopeptidases to fit on the Class I MHC binding
site formed by the Class I a chain in association with b2
microglobulin. Peptide-bound Class I complexes are then released
from tapasin-chaperone complexes to be delivered to the cell
surface, where they can interact with cytolytic CD8
+ T cells
leading to destruction of the infected cells. In addition, Class I
MHC antigen presentation is up-regulated by INFa, b, and c as
well as by LT and TNFa. As shown in Figure 5 and Figure 6, we
have determined that several genes involved in Class I MHC
antigen presentation harbour validated binding sites for IRF8,
and/or are regulated in macrophages upon exposure to IFNc/
CpG and/or in the lungs of M. tuberculosis-infected mice in vivo.
These include the PA28 subunit of the proteasome, the TAP1/
TAP2 transport system and associated tapasin (Tapap), ER
aminopeptidase (Erap1), as well as Class I MHC a chain, b2
microglobulin and associated ER chaperone Calnexin.
On the other hand, antigen presentation via the Class II MHC
pathway is carried out by specialized APCs. It involves antigen
capture via the endosomal or phagosomal routes through initial
interaction with specific cell surface receptors of the TLR (Toll-like
receptor), C3R (complement-3 receptor), FcR (Fc receptor) and Ig
(immunoglobulin) families. These antigens are digested by
members of the cathepsin family of Cys/Asp proteases in acidic
endosomes, lysosomes and phagolysosomes. Class II MHC a and
b chains stabilized by chaperones are associated with non-
polymorphic Ii protein which prevents antigen binding at the a/
b interface. Delivery of this complex to antigen-containing
acidified endosomes/lysosomes causes proteolytic degradation of
Ii (Cd74), leaving only the CLIP (Class II-associated invariant
chain peptide) portion of Ii in the antigen binding site. This CLIP
peptide is then removed by the HLA-DM (major histocompati-
bility complex, class II, DM) protein (H2M in mice), freeing up the
antigen binding site. Antigen-bound Class II complexes are
delivered to the cell surface where they can interact with CD4
+
helper T cells to induce production of effector T cells, activation of
macrophages to microbicidal function, and antibody production
depending on the type of APC involved. The process of Class II
MHC antigen presentation can itself be stimulated by secretory
products of APCs (e.g IL12) or T cells (IFNc). As shown in
Figure 4, Figure 5, and Figure 6, our analysis shows that several
genes of the Class II antigen presentation pathway harbour IRF8
binding sites and/or are regulated in macrophages upon exposure
to IFNc/CpG and/or during pulmonary tuberculosis. These
include Tlr4/9/13, members of the Cathepsin family of proteases,
Class II MHC molecules, Ii, and HLA-DM. Together, these
results establish a critical role for IRF8 in regulation of the key
programmes of antigen presentation in APC. These results are in
Figure 6. The IRF8 binding sites are strongly associated with antigen presenting cells function. (A) Schematic representation of the
‘‘antigen processing and presentation’’ pathway. Adapted from the KEGG pathway database [61,62] and current literature [63]. Genes implicated in
Class I and Class II MHC antigen processing and presentation were annotated for IRF8 binding (blue box), for activated by IFNc-CpG (green box), and
for activation by infection with M. tuberculosis (red outline). These results suggest that IRF8 is a key regulator of all steps of the antigen processing
and presentation pathway. (B) Validation of Cd74 (Ii) at protein level. BMDMs total proteins were obtained from wt (B6) and IRF8 mutant (BXH2) mice
either prior to (unstimulated control) or following stimulation with IFNc/CpG (4 hrs and 24 hrs post-stimulation), separated in 10% SDS-PAGE and
probed with In-1 mAb. The migration of intact p41 and p31 Ii, as well as SLIP Ii fragment (,12-kD) is indicated. a-tubulin was used as a constitutively
expressed internal control to normalize the protein levels.
doi:10.1371/journal.pgen.1002097.g006
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mutant mice in the DCs compartment, as they lack both
CD11c
+CD8a
+ DCs and pDCs, and the small number of
CD11c
+CD8a
+ and CD8a
2 DCs present in these mice remain
immature and fail to up-regulate co-stimulatory molecules and
produce key cytokines in response to microbial products in vitro
and in vivo during pulmonary tuberculosis [18,26]. Macrophage
maturation including expression of cytocidal function is also
impaired in IRF8-deficient mice, and their macrophages are
susceptible to infection with intracellular pathogens in vitro [14,15].
Many of the genes implicated in Class I and Class II MHC
antigen presentation are located within the boundaries of the
MHC locus. In this locus, we note a striking over-representation
of binding sites for IRF8 and the number of genes which
expression is regulated by IFNc/CpG in macrophages. In the
case of genes bound by IRF8 and regulated by IFNc/CpG in
macrophages (199 probes, corresponding to 145 genes genome
wide), ,10% of them map to the MHC region on Chr. 17, with
11 binding sites mapping near 16 regulated genes. This
concentration of direct IRF8 targets genes corresponds to a 14
fold enrichment over genome-wide representation of these 145
genes. Likewise, ,10% of the genes regulated by M. tuberculosis
infection in vivo and that contain a IRF8 binding site in their
vicinity map to the MHC locus (9 fold enrichment), with 12 IRF8
binding sites mapping near 27 regulated genes (Figure 5). The
regulatory role of IRF8 in the MHC locus also seems to include
additional genes playing a central role in amplification of early
immune response, such as TNFa, LT, and components of the
complement pathway. IRF8-dependent transcription of MHC-
linked genes may involve direct cis-acting effects of IRF8 binding
to de novo motifs identified in our study, or may additionally
involve amplification through activation of other transcription
factors. For example, Ciita (class II, major histocompatibility
complex, transactivator) is a non-DNA binding co-activator that
binds to the so-called ‘‘MHCII enhanceosome’’ multiprotein
complex and that serves as a master control factor for MHCII
gene expression [44]. Ciita expression is up-regulated by IFNc in
a STAT1-dependent fashion; through the presence of GAS
(Gamma interferon activation site) element in the proximal PIV
responsive promoter in the Ciita gene [45]. Moreover, we
observed that Ciita expression is tightly regulated by IFNc/
CpG in an IRF8-dependent fashion in macrophages from F2
mice (262 interaction Anova analysis; Table S3), and is also
regulated in pulmonary tuberculosis. The PIV promoter region of
Ciita also contains a de novo IRF8 binding motif, and a cluster of
weak binding sites were experimentally detected in this region by
ChIP-chip (data not shown). Therefore, it is possible that IRF8-
mediated control of MHC gene expression involves amplification
by other transcriptional regulators such as Ciita.
Furthermore, our study points at an important role of IRF8 in
transcriptional activation of several families of IFN-inducible
intracellular GTPases of the p47 (IRG), p65 (GBPs) and Dynamin
(Mx) families which are known to be essential for protection
against intracellular bacterial, parasitic and viral infections
(Figure 4C) [40]. The p47 family of immunity-related GTPase
(IRGs) contains 18–23 members in mice, with 6 having been
characterized in some details [40,41]. They are expressed at low
levels in different cell types, but mainly myeloid cells, and show
dramatic up-regulation upon exposure to IFNc. Studies in mutant
mice have shown that deficiency in Lrg47/Irgm1 causes
susceptibility to infection with M. tuberculosis [46,47], while absence
of Igtp/Irgm3 and Iigp1/Irga6 causes intracellular replication of
Toxoplasma gondii [48,49]. In macrophages, the Irgm1 protein is
rapidly recruited to the membrane of bacteria-containing
phagosomes, where it is believed to facilitate delivery of lysosomal
cargo for the destruction of intracellular pathogens, a process that
is critically dependent on phosphatidylinositol 3,4 bisphosphate
(PI3,4P2) and PI3,4,5P3 [50]. As expected, we observed increased
expression of several IRGs in macrophages in response to IFNc
and in vivo in M. tuberculosis infected lungs (Figure 4C), but we also
detected at least one IRF8 binding site near Irgm1, with two
weaker sites near Irg-47 and Irgm3. Unfortunately, several of the
IRGs promoter regions were not present on the arrays we used,
and more experimentation will be required to determine if IRF8
binding sites are present at or near other IRG genes. The family of
p65 GBP contains 11 members in mice that map to two gene
clusters on chromosomes 3 (Gbp1, 2, 3, 5, 6, 13) and 5 (Gbp4, 8, 9,
10, 11, 12) [39,41]. Gbp mRNAs are induced by IFNc in
macrophages in vitro, and in spleen, liver and lungs of mice infected
with intracellular pathogens Listeria monocytogenes and T. gondii [39].
Subcellular localization studies have shown that several Gbp
family members are quickly recruited to the membrane of
microbe-containing phagosomes formed in infected fibroblasts
[39]. Like Irg proteins, Gbps also traffic to pathogen vacuoles to
potentially deliver microbicidal products to restrict intracellular
replication. We have detected by ChIP-chip 3 IRF8 binding sites
on the chromosome 3 cluster that are associated with regulation of
several of these Gbps (Gbp2, 3, 5, 6) in response to IFNc or M.
tuberculosis infection. We have validated at the protein level the
IRF8-dependence of basal and IFNc/CpG inducible expression of
Cd74 (and its cleavage product SLIP) (Figure 6B), and Gbp1 in
macrophages (Figure S2), with more modest effects noted at the
protein level for Gbp2, Gbp3 and Irgm 1 (Figure S2). Although
transcriptional activation of the Irg and Gbp genes by IFNc was
previously associated with the presence of GAS (Gamma
interferon activation site) and ISRE elements in their promoter
region, and activation via the Jak/Stat pathway and IRF1 [41],
our results strongly suggest that IRF8 may additionally be involved
in this regulation. Moreover, the study of Irgm3
2/2 mutant mice
has identified defects in antigen cross-presentation in these mice
[51]. Interestingly, it has been proposed that IRG proteins (and
possibly Gbps) may not only be involved in the delivery of
lysosomal cargo to bacterial-containing phagosomes, but may also
be involved in facilitating transport of antigen containing lipid
droplets for antigen cross-presentation by Class I MHC molecules
[51]. Although speculative, this proposal is in agreement with the
observed role of IRF8 in directing transcriptional networks
associated with antigen presentation by Class I and Class II
MHC molecules.
Finally, a recent study [31] used a combination of IRF8 ChIP-
chip and expression profiling in IRF8 knocked down human
myelomonocytic leukemia THP-1 cells to identify primary and
secondary IRF8 targets in these cells. In agreement with the de novo
IRF8 binding motif described herein (Figure 3A and Figure S1A),
previous gene specific studies [52–55] and our binding motif
association study (Figure 3C), these authors demonstrated a
significant overlap between IRF8 and PU.1 ChIP-chip binding
locations. They identified development and differentiation genes
affected by the loss of IRF8, but also immune response genes as
direct targets. The list of 84 IRF8 primary targets was compared to
our results (Table S8). This list shows a 43% overlap with our list
of IRF8 binding peaks, a 21% overlap with our list of genes
regulated by IFNc/CpG in a IRF8-dependent fashion, and 70%
overlap with the list of genes differentially regulated during
pulmonary tuberculosis in vivo. Therefore, the overlaps between
the IRF8 target genes identified in both studies is fairly important.
Together, these studies emphasize the predominant role of IRF8
in myeloid cell functions.
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Animals
C57BL/6J (B6) mice were purchased from the Jackson
Laboratory (Bar Harbor, ME). Recombinant inbred BXH2 mice
were originally derived by B. Taylor at the Jackson Laboratory
[56] and subsequently maintained as a breeding colony at McGill
University. BXH2 males were used to generate [BALB/
cJ6BXH2]F1 mice, which were then inter-crossed to produce an
F2 progeny. F2 littermates homozygote for either the wt (R294;
IRF8
+/+) or mutant (C294; IRF8
R294C/R294C) IRF8 allele were
identified and used in the transcript profiling experiments. IRF8
alleles were identified by genotyping for the proximal marker
D8Mit13 using oligonucleotide primer pairs 59-CCTCTCTC-
CAGCCCTGTAAG-39 and 59-AACGTTTGTGCTAAGTGG-
CC-39, which distinguishes between BALB/cJ and C57BL/6J, the
strain background of the IRF8 genomic segment onto which the
R294C mutation appeared in BXH2 [9]. The isolation of genomic
DNA, and the genotyping for D8Mit13 alleles were carried out as
described [9]. Male and female mice 8 to 12 weeks of age were
used for all experiments, according to guidelines and regulations of
the Canadian Council on Animal Care.
Macrophages and Stimulation
The mouse macrophage cell line J774 was grown in Dulbecco’s
modified Eagle’s medium (DMEM, Sigma) supplemented with
10% heat-inactivated fetal bovine serum (HI-FBS, GIBCO),
100 U/ml penicillin, and 50 mg/ml streptomycin (Invitrogen) at
37uC, in 5% CO2-containing humidified air. BMDMs were
isolated from femurs of 8- to 12-week-old mice and were cultured
in DMEM (Sigma) containing 10% heat-inactivated fetal bovine
serum (HI-FBS), 20% L-cell-conditioned medium (LCCM),
100 U/ml penicillin, and 100 mg/ml streptomycin in bacteriolog-
ical grade dishes (Fisher) at 37uC in a humidified atmosphere
containing 5% CO2. Seven days later, cells were harvested by
gentle washing of the monolayer with phosphate-buffered saline
containing citrate. Cells were plated in 150-mm tissue culture-
grade plastic plates (18610
6 cells per plate; Corning) in DMEM
containing 10% HI-FBS, 10% LCCM, 100 U/ml penicillin, and
100 mg/ml streptomycin. In some experiments, macrophages were
primed with IFNc (50 U/ml) for 18 hrs, prior to stimulation
(3 hrs) with recombinant mouse IFNc (Cell Sciences, Canton,
MA), and CpG DNA oligonucleotides (59-TCCAT-
GACGTTCCTGACGTT-39) used at a concentration of
400 U/ml and 1,5 mg/ml, respectively. IFNc and CpG stimulate
both the IFNc receptor and Tlr9, and engagement of both
receptors stimulates IRF8 expression, via STAT1, NFKB and
possibly other pathways [11].
Transcript Profiling with Microarrays
Total RNA was extracted from BMDMs obtained from 6
individual mice per experimental group, either prior to or 3 hrs
following stimulation of BMDMs with IFNc (400 U/ml) and CpG
DNA (1,5 mg/ml). IFNc/CpG-stimulated macrophages were
initially primed with IFNc (50 U/ml) for 18 hrs. Purified RNAs
were analyzed for integrity by gel electrophoresis, and were then
hybridized to microarrays (Illumina Mouse WG-6 v2.0 Expression
BeadChip) according to the manufacturer’s recommended exper-
imental protocol. To minimize technical variability, RNA
processing steps (RNA extraction, probe labeling and microarray
hybridization) were executed in parallel for all samples. The
GeneSifter
TM microarray data analysis system (Geospiza Inc.,
Seattle, WA, USA) was used to examine data generated from
comparisons between control (unstimulated) and IFNc/CpG-
stimulated (3 hrs) groups. Log transformed data were normalized
and transcripts showing differential expression were identified by
pairwise, or two-way (262 interaction) Anova analysis with a t test
p value of 0.05 and a fold-change cutoff of 1.5X. Hierarchical
clustering based on complete linkage method was applied to
evaluate the effect of the different sources of variability (IRF8
alleles, treatments, host specific responses). Complete microarray
data (accession no. E-MEXP-2962) has been deposited in the
ArrayExpress database (www.ebi.ac.uk/microarray-as/ae/).
Quantitative PCR
The expression of individual mRNAs was measured by
quantitative PCR (qPCR) amplification of cDNA transcripts
generated by reverse transcriptase (RT). Briefly, RNA samples
(n=6) used for transcriptional profiling were pooled and 3 mgo f
pooled RNA was converted to cDNA using Moloney murine
leukemia virus (Invitrogen) in a 20 ml reaction according to the
manufacturer’s recommended experimental protocol. PCR am-
plification was performed using Quantitech SYBR Green PCR kit
(Qiagen), and all samples were measured in duplicate. Each
reaction contained 2 ml of cDNA template, 1 ml of the target-
specific primer pair (each primer at 5 mM), 9.5 ml of RNase-free
water and 12.5 ml of Quantitech SYBR Green PCR master mix.
PCR amplification included an initial denaturation step (10 min at
95uC) followed by 50 cycles of amplification (15 s at 95uC, 30 s at
57uC, and 33 s at 72uC), and was performed using the 7500 Real
Time PCR system (Applied Biosystems). PCR primers were
designed to generate amplicons ranging from 100 to 150 bp. The
Hprt gene was used as a constitutively expressed internal control to
normalize the mRNA levels of target genes.
Western Blot Analysis
BMDMs were obtained from wt (B6) and IRF8 mutant (BXH2)
mice, either prior to or following stimulation (4 and 24 hrs) with
IFNc (400 U/ml) and CpG DNA (1,5 mg/ml). Whole cell extracts
(75 mg per lane) were subjected to 10% sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS–PAGE), followed by
electroblotting and overnight incubation with the monoclonal
anti-Cd74 (Ii) antibody (clone In-1 purchased from BD Pharmin-
gen) (used at 1:200). Immune complexes were revealed with a
horseradish peroxidase-conjugated goat anti-rat antibody (used at
1:3000) and visualized by enhanced chemiluminescence (Super-
Signal West Pico kit, Thermo Scientific, Rockford, IL). Intact p41
and p31 Ii, as well as SLIP Ii fragment (contains the NH2-terminal
portion of Ii) are all detected by the In-1 mAb [57]. Antibodies,
dilutions and source dilutions for the immune GTPases were:
Irgm1 (A19, 1:200), Irgm3 (M14, 1:200), Irga6 (G20, 1:200), Irgb6
(A20, 1:200), Gbp1 (M18, 1:200), Gbp2 (M15, 1:1000), Gbp5
(L12, 1:500) were from Santa Cruz Biotechnology; Gbp3 (Abcam,
1:200), Beta actin (Sigma, 1:1000).
Chromatin Immunoprecipitation (ChIP)
ChIP assays were performed on J774 macrophages stimulated
with IFNc/CpG for 3 hours, according to a method previously
described [58,59]. Stimulated cells were treated with formalde-
hyde (1% final; 10 min, 20uC), washed with ice-cold PBS, and
cross-linked cells were harvested by centrifugation. The cell pellet
was resuspended in 1 mL of cell lysis buffer (1% SDS, 10 mM
EDTA, 50 mM Tris-HCl pH 8) supplemented with a cocktail of
protease inhibitors, followed by sonication on ice. Chromatin was
recovered by centrifugation (13,000 g, 7 min, 4uC), and resus-
pended in ChIP dilution buffer (0.5% Triton X-100, 2 mM
EDTA, 100 mM NaCl, 20 mM Tris-HCl pH 8.1) followed by
pre-clearing using a 50% slurry of salmon sperm DNA/protein G
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complexes were immunoprecipitated (4uC, 16 hrs) using an anti-
IRF8 antibody (sc-6058x; Santa Cruz), followed by addition of
50% slurry of salmon sperm DNA/protein G beads (600 mL; 3 hr,
4uC) on a rotating device. Control and anti-IRF8 immunoprecip-
itates were washed (10 min) sequentially with each of the following
buffers: low salt Buffer I (1% Triton X-100, 0.1% SDS, 150 mM
NaCl, 2 mM EDTA pH 8.0, 20 mM Tris-HCl pH 8.1), high salt
Buffer II ( 1% Triton X-100, 0.1% SDS, 500 mM NaCl, 2 mM
EDTA pH 8.0, 20 mM Tris-HCl pH 8.1) and Buffer III (1%
IGEPAL, 0.25 mM LiCl, 1% Na-deoxycholate, 1 mM EDTA
pH 8.0, 10 mM Tris-HCl pH 8.1), and a brief final wash in TE
buffer (10 mM Tris-HCl pH 7.5, 1 mM EDTA pH 8). DNA was
recovered from immunoprecipitated IRF8 chromatin complexes
by incubation in a buffer containing 1% SDS and 0.1 M
NaHCO3 (65uC, 16 hrs), and further purified using the QIAquick
PCR purification kit (Qiagen).
Sample Preparation for Hybridization to Mouse Extended
Promoter Arrays (ChIP-Chip)
Sample preparation for hybridization to promoter arrays was
carried out as recommended in Agilent Mammalian ChIP-on-chip
protocol, with minor modifications. Briefly, the ChIP DNA was
amplified by ligation-mediated PCR (LM-PCR) following DNA
blunting and linker ligation. The LM-PCR samples were purified
on QIAquick purification columns and submitted to 18 additional
rounds of amplification in the presence of aminoallyl-dUTP (final
concentration 300 mM; Sigma). The LM-PCR samples containing
aminoallyl-dUTP were purified (QIAquick PCR purification
columns) and labeled with Cy3 and Cy5 dies. The DNA amount
was calculated by using the OD at 260 and 320, and the Cy3 and
Cy5 incorporation was also determined.
Agilent ChIP-Chip Hybridization and Analysis
Samples were hybridized to Agilent 244K mouse extended
promoter arrays containing ,17,000 of the best-defined mouse
transcripts as defined by RefSeq spanning the regions from
25.5 kb upstream to +2.5 kb downstream of the transcription
start site. The procedure was done according to the Agilent
mammalian ChIP on chip protocol version 9.2. Following the
hybridization at 65uC for 40 hrs, the arrays were washed and
scanned using a GenePix 4000B scanner and data was extracted
from the images using Agilent Feature Extraction software as
described in the mammalian ChIP on chip protocol (Agilent, v.10).
Data from ChIP-chips were normalized and averaged using ChIP
Analytics 1.3 software. Data was processed in ChIP Analytics
using the intra-array Lowess normalization, Whitehead Error
Model v1.0 and Whitehead Per-Array Neighbourhood Model v1.0
for peak detection and evaluation. The default parameters were
used to identify significant binding events (1000 bp as the
maximum distance for 2 probes to be considered neighbors in a
probe set, probe set p-value,0.001 for a ‘‘bound’’ probe).
Transcription Factor Binding Motifs Analyses
We retrieved from the UCSC genome browser 500 bp
sequences centered on each 319 IRF8 ChIP-chip and performed
de novo binding motif analyses with 3 different algorithms: MEME
[32], MDscan [33] and AlignACE [34]. The resulting matrices
were compared to the Transfac v11.3 known binding motif
database using the STAMP web-tool [35]. The schematic
representations of the IRF8 de novo binding motif were generated
with WebLogo [60]. The 319 IRF8 binding regions were queried
for all known binding motifs on 1000 bp sequences using the
optimized matrix threshold from MatInspector software (Geno-
matix). Then, we searched for the same motifs on five sets of 319
randomly chosen 1000 bp sequences, selected from Agilent 244K
mouse extended promoter array oligos. Thereafter, we calculated
enrichment of binding motifs between the IRF8 binding regions
and the mean of motif occurrence in random sequence sets (Table
S5).
Gene Ontology (GO) and Pathway Analyses
We used the DAVID (database for annotation, visualization and
integrated discovery) website to calculate GO and KEGG (Kyoto
encyclopedia of genes and genomes) pathways enrichment in our
different ChIP-chip and expression datasets (DAVID threshold set
to p value#0.001) [36,37]. The Agilent 244K mouse extended
promoter array or Illumina Mouse WG-6 v2.0 Expression
BeadChip complete gene lists were used as reference respectively
for enrichment evaluation.
Supporting Information
Figure S1 De novo transcription factor binding motif analyses
on IRF8 ChIP-chip binding sites. (A) 500 bp of sequence flanking
the 319 IRF8 binding peaks were queried for de novo motif finding
with three different algorithms: MEME, MDscan and AlignACE
[32–34]. The top motifs returned by each algorithm are highly
similar. (B) Weight matrix representation of the known Transfac
IRF8 (Icsbp) binding motif.
(TIF)
Figure S2 Validation of members of the Gbp (p65) and Irgm
(p47) families at protein level. BMDMs total proteins were
obtained from wt (B6) and IRF8 mutant (BXH2) mice either
prior to (unstimulated control) or following stimulation with IFNc/
CpG (4 hrs and 24 hrs post-stimulation), separated in 10% SDS-
PAGE (35 mg of lysate/lane) and probed with specific antibodies.
b-actin was used as a constitutively expressed internal control to
normalize the protein levels.
(TIF)
Table S1 Genes differentially regulated at basal level in wt
versus IRF8 mutant macrophages (pairwise analysis).
(XLS)
Table S2 Genes differentially regulated in wt versus IRF8
mutant macrophages at basal level, and modulated by IFNc/CpG
stimulation (pairwise analysis).
(XLS)
Table S3 Genes differentially modulated by IRF8 in wt versus
IRF8 mutant BMDMs in response to IFNc/CpG exposure (two-
way Anova; 262 interaction).
(XLS)
Table S4 List of IRF8 ChIP-chip binding sites.
(XLS)
Table S5 Known transcription factor binding motifs enrichment
analysis.
(XLS)
Table S6 Gene Ontology and KEGG pathways enrichment
analysis.
(XLS)
Table S7 Intersection between IRF8 ChIP-chip binding sites
and differentially regulated genes in IFNc/CpG treated F2 mice
or M. tuberculosis-infected B6 mice for 30 days.
(XLS)
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and those from the present study.
(XLS)
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